D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients

被引:146
作者
Shorr, AF [1 ]
Thomas, SJ [1 ]
Alkins, SA [1 ]
Fitzpatrick, TM [1 ]
Ling, GS [1 ]
机构
[1] Walter Reed Army Med Ctr, Washington, DC 20307 USA
关键词
ARDS; critical illness; cytokine; d-dimer; death; outcomes; sepsis;
D O I
10.1378/chest.121.4.1262
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: To determine the relationship between d-dimer (DD) and both proinflammation, and anti-inflammatory cytokine levels, and to confirm the association between DD status and Outcomes in critically ill patients. Design: Prospective observational study. Setting: Medical ICU (MICU) of a tertiary care, academic medical center. Patients: Individuals admitted to the MICU. Interventions: Within 24 h of MICU admission, patients had DD status determined and interleukin (IL) levels (IL-6, IL-8, and IL-10) and tumor necrosis factor (TNF)-alpha measured. The strength of the DD level was also noted. Subjects were then monitored prospectively to determine mortality rate and the incidence of organ failure. Measurement and results: The study cohort included 79 patients (mean age, 65.2 years; 54.5% male patients). DD was present in 53.2% of subjects. The DD reaction was weak (1+) in 15 patients and strong (2+) in 27 patients. The TNF-alpha, IL-6, and IL-8 levels all increased in parallel with the increasing strength of the DD level. IL-10 levels did not differ based on DD status. Similarly, the severity of illness as measured by the APACHE (acute physiology and chronic health evaluation) II score was highest among those with higher DD levels: 24.7 +/- 6.2 for those with 2+ DD vs 17.2 +/- 3.1 and 11.5 +/- 2.7 for those with 1+ DD and no circulating DD, respectively (p < 0.001). For patients lacking DD, the mortality rate as 8.1%, Compared to 13.3% and 55.6% for those with 1+ and 2+ DD levels, respectively (1) < 0.001). No patient without DD had multisystem organ failure (MSOF) develop, while the incidence of MSOF also increased with increasing DD levels. As a screening test for mortality, the DD performed as well as the APACHE II system. Conclusions: The coagulation system is active in critically ill patients, and DD levels correlate with activation of the proinflammatory cytokine cascade. The absence of a relationship between DD and anti-inflammatory cytokines (IL-10) suggests that the presence of DD may reflect the imbalance between proinflammatory and anti-inflammatory cytokines. DD identifie's patients at increased risk for both MSOF and death.
引用
收藏
页码:1262 / 1268
页数:7
相关论文
共 32 条
[1]  
Ahearn GS, 2000, SEMIN RESP CRIT CARE, V21, P521
[2]   Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock [J].
Balk, RA .
CRITICAL CARE CLINICS, 2000, 16 (02) :337-+
[3]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[4]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[5]   Changes of the hemostatic network in critically ill patients - Is there a difference between sepsis, trauma, and neurosurgery patients? [J].
Boldt, J ;
Papsdorf, M ;
Rothe, A ;
Kumle, B ;
Piper, S .
CRITICAL CARE MEDICINE, 2000, 28 (02) :445-450
[6]   THE ACCP-SCCM CONSENSUS CONFERENCE ON SEPSIS AND ORGAN FAILURE [J].
BONE, RC ;
SIBBALD, WJ ;
SPRUNG, CL .
CHEST, 1992, 101 (06) :1481-1482
[7]   Circulating endothelin-1 and tumor necrosis factor-α:: early predictors of mortality in patients with septic shock [J].
Brauner, JS ;
Rohde, LE ;
Clausell, N .
INTENSIVE CARE MEDICINE, 2000, 26 (03) :305-313
[8]   SOLUBLE FIBRIN - A PREDICTOR FOR THE DEVELOPMENT AND OUTCOME OF MULTIPLE ORGAN FAILURE [J].
BREDBACKA, S ;
BLOMBACK, M ;
WIMAN, B .
AMERICAN JOURNAL OF HEMATOLOGY, 1994, 46 (04) :289-294
[9]  
DINARELLO CA, 1997, CHEST, V112, P3215
[10]  
ESMON CT, 1991, THROMB HAEMOSTASIS, V66, P160